Clin2
NCT06916338Possibly a fitRecruiting

PET imaging study using 18F-FAPI-04 for breast cancer

Breast Cancer

Part of Cancer, Skin clinical trials.

This study tests a new imaging agent (18F-FAPI-04) for PET scans to see if it can better detect breast cancer or its spread. It may help doctors find tumors more clearly.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
30 people
Ages
18 years to 75 years
Study type
Observational

Who can take part

  • You are between 18 and 75 years old.
  • You have breast cancer that is confirmed or suspected to have come back or spread.
  • You have at least one tumor that can be measured on a scan.
  • You are well enough to perform daily activities (ECOG score 0-2) and are expected to live at least 12 weeks.
  • Your blood counts and liver/kidney function are within acceptable ranges (check with your doctor).
  • You are willing and able to give informed consent.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07012707Not yet recruiting
Study of 18F-FAPI PET/CT for breast cancer lymph node detection

This study tests a new kind of PET/CT scan that uses a tracer called 18F-FAPI to see if it can better detect cancer in the lymph nodes under the arm after you've already had chemotherapy or targeted therapy before surgery. If successful, this could help doctors plan more precise surgery and avoid removing unnecessary lymph nodes.

NCT07705074Not yet recruiting· Phase 1/Phase 2
FAPI PET imaging study for cancer and other diseases

This study uses a special type of PET scan called FAPI PET to see if it can help detect or monitor cancer and other diseases. It is for people who already need a PET or CT/MRI scan as part of their standard care.

Baden, Canton of Aargau
NCT07285993Not yet recruiting· Phase 2
New PET scan for invasive lobular breast cancer

This trial tests a special PET scan (F-FAPI PET) to image metastatic invasive lobular breast cancer. It aims to see if this scan gives a clearer picture than the standard PET scan, helping doctors track the cancer better.

New York, New York
NCT06335069Recruiting· Phase 2
Comparing two PET tracers in ER-positive breast cancer

This trial compares two types of PET scans to see which one better detects ER-positive breast cancer. The results could help doctors choose the best scan for tracking your cancer.

Maastricht
NCT07180433Not yet recruiting
FAPI PET/MRI imaging for breast cancer

This trial tests a new imaging method (FAPI PET/MRI) to see if it can help evaluate breast cancer. It focuses on people with invasive breast cancer who are about to start treatment before surgery or who have recurrent or new breast cancer.

NCT06557590Recruiting
PET scan with FAPI tracer for cancer imaging

This study uses a special PET scan called 18F-FAPI-04 to take detailed images of different kinds of cancer. It aims to see if this scan can help doctors better find and monitor tumors.

Changsha, Hunan

Hear when a new Breast cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.